Investors & Media

Investors & Media

Corporate Profile

At Travere Therapeutics, our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.

Volume: 52 Week High: 52 Week Low:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

Dec 01, 2020
SAN DIEGO , Dec. 01, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that the Company will host a virtual R&D Day on Wednesday, December 9, 2020 at 12:00 p.m. ET to review the Company’s key pipeline programs. The event will feature presentations from external experts
Nov 16, 2020
New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies In Rare for Life Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on November 19 SAN DIEGO , Nov. 16, 2020 (GLOBE NEWSWIRE) -- Retrophin Inc.